Faculty: Wendy H. Vogel, MSN, FNP, AOCNP
CME Accreditation for this article expired on May 31, 2016.
Learning Objectives (Outcomes)
Upon completion of this module, participants will be able to:
- Describe Methotrexate treatments and its association with renal dysfunction
- Identify patients with or at risk for toxic plasma methotrexate
- Define and explain appropriate strategies for preventing and managing toxic plasma methotrexate
- Name the indications and usage recommendations for glucarpidase
- List possible drug interactions and side effects with glucarpidase
CME Disclosure to the Readers
A review has been conducted by the CEE CME Committee that includes evaluation of objectives, content, faculty qualifications, and commercial supporters (i.e. pharma companies, instrument or device manufacturers) to comply with, and ensure the Institute for Medical Quality (IMQ)/California Medical Association (CMA) and Accreditation Council for Continuing Medical Education (ACCME) standards are met.
In accordance with the standards of commercial support of the IMQ/CMA and ACCME, all planners and speakers are asked to disclose any real or apparent conflicts of interest, which may have a direct bearing on the subject matter they will be presenting in this article.
All authors and planners have disclosed that they have no relevant conflicts of interest and forms are on file for review.
Successful completion of this activity requires a completed post-test and evaluation. You will then print your CME/CE Certificate from the website.
For any CME related inquiry, please contact email@example.com.
This article is sponsored by The Center of Excellence in Education.
This article is funded through an educational grant through a commercial supporter. The Center of Excellence in Education ensures that its activities are educational and meet the needs of the target audience.
This educational activity is developed without influence from commercial supporters.
This educational activity is supported by an educational grant from BTG International Inc. in accordance with industry standards.
This article does not endorse any commercial products.